Page 29 - Read Online

Vong et al. J Cancer Metastasis Treat 2020;6:54 I http://dx.doi.org/10.20517/2394-4722.2020.116 Page 11 of 11

2. Beigel JH, Tomashek KM, Dodd LE, et al. Remdesivir for the treatment of Covid-19- preliminary report. N Engl J Med 2020;383:994.
3. Group RC, Horby P, Lim WS, et al. Dexamethasone in hospitalised patients with Covid-19 - preliminary report. N Engl J Med
2020;NEJMoa2021436.
4. gov.sg. What do the different DORSCON levels mean 2020. Available from: https://www.gov.sg/article/what-do-the-different-dorscon-
levels-mean. [Last accessed on 8 Dec 2020]
5. National centre for infectious diseases (NCID). About NCID. Available from: https://www.ncid.sg/About-NCID/Pages/default.aspx. [Last
accessed on 8 Dec 2020]
6. Urun Y, Hussain SA, Bakouny Z, et al. Survey of the impact of COVID-19 on Oncologists’ decision making in cancer. JCO Glob Oncol
2020;6:1248-57.
7. London JW, Fazio-Eynullayeva E, Palchuk MB, Sankey P, McNair C. Effects of the COVID-19 pandemic on cancer-related patient
encounters. JCO Clin Cancer Inform 2020;4:657-65.
8. Maringe C, Spicer J, Morris M, et al. The impact of the COVID-19 pandemic on cancer deaths due to delays in diagnosis in England,
UK: a national, population-based, modelling study. Lancet Oncol 2020;21:1023-34.
9. Report of the WHO-China joint mission on coronavirus disease 2019 (COVID-19) 2020. Available from: https://www.who.int/docs/
default-source/coronaviruse/who-china-joint-mission-on-covid-19-final-report.pdf. [Last accessed on 8 Dec 2020]
10. Wu ZY, McGoogan JM. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China:
summary of a report of 72314 cases from the Chinese Center for Disease Control and Prevention. JAMA 2020;323:1239-42.
11. National University Cancer Institute of Singapore Workflow T. A segregated-team model to maintain cancer care during the COVID-19
outbreak at an academic center in Singapore. Ann Oncol 2020;31:840-3.
12. Tan BF, Tuan JKL, Yap SP, Ho SZ, Wang MLC. Managing the COVID-19 pandemic as a national radiation oncology centre in Singapore.
Clin Oncol (R Coll Radiol) 2020;32:e155-9.
13. Desai A, Sachdeva S, Parekh T, Desai R. COVID-19 and cancer: lessons fom a pooled meta-analysis. JCO Glob Oncol 2020;6:557-9.
14. Kuderer NM, Choueiri TK, Shah DP, et al. Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study. Lancet
2020;395:1907-18.
15. Lee LYW, Cazier JB, Starkey T, et al. COVID-19 mortality in patients with cancer on chemotherapy or other anticancer treatments: a
prospective cohort study. Lancet 2020;395:1919-26.
16. Solodky ML, Galvez C, Russias B, et al. Lower detection rates of SARS-COV2 antibodies in cancer patients versus health care workers
after symptomatic COVID-19. Ann Oncol 2020;31:1087-8.
17. Garassino MC, Whisenant JG, Huang LC, et al. COVID-19 in patients with thoracic malignancies (TERAVOLT): first results of an
international, registry-based, cohort study. Lancet Oncol 2020;21:914-22.
18. Luo J, Rizvi H, Preeshagul IR, et al. COVID-19 in patients with lung cancer. Ann Oncol 2020;31:1386-96.
19. Shi HS, Han XY, Jiang NC, et al. Radiological findings from 81 patients with COVID-19 pneumonia in Wuhan, China: a descriptive
study. Lancet Infect Dis 2020;20:425-34.
20. Guckenberger M, Belka C, Bezjak A, et al. Practice recommendations for lung cancer radiotherapy during the COVID-19 pandemic: an
ESTRO-ASTRO consensus statement. Radiother Oncol 2020;146:223-9.
21. Dingemans AC, Soo RA, Jazieh AR, et al. Treatment guidance for patients with lung cancer during the coronavirus 2019 pandemic. J
Thorac Oncol 2020;15:1119-36.
22. National Comprehensive Cancer Network. Short-term recommendations for non-small cell lung cancer management during the
COVID-19 pandemic. JCO Oncology Practice 2020;16:579-86.
23. Curigliano G, Banerjee S, Cervantes A, et al. Managing cancer patients during the COVID-19 pandemic: an ESMO interdisciplinary
expert consensus. Ann Oncol 2020;31:1320-35.
24. ESMO. ESMO management and treatment adapted recommendations in the COVID-19 era: lung cancer 2020 16/08/2020. Available
from: https://www.esmo.org/guidelines/cancer-patient-management-during-the-covid-19-pandemic/lung-cancer-in-the-covid-19-era. [Last
accessed on 8 Dec 2020]
25. Passaro A, Addeo A, Von Garnier C, et al. ESMO management and treatment adapted recommendations in the COVID-19 era: lung
cancer. ESMO Open 2020;5:e000820.
26. Ternyila D. Recommendations for managing patients with lung cancer during COVID-19 Era: Targeted Oncology; 2020 Available from:
https://www.targetedonc.com/view/recommendations-for-managing-patients-with-lung-cancer-during-covid-19-era. [Last accessed on 8
Dec 2020]
27. Sia CH, Tan BY, Ooi SBS. Impact of the coronavirus disease 2019 pandemic on postgraduate medical education in a Singaporean
academic medical institution. Korean J Med Educ 2020;32:97-100.
28. Sidpra J, Gaier C, Reddy N, Kumar N, Mirsky D, Mankad K. Sustaining education in the age of COVID-19: a survey of synchronous
web-based platforms. Quant Imaging Med Surg 2020;10:1422-7.
29. Byrnes KG, Kiely PA, Dunne CP, McDermott KW, Coffey JC. Communication, collaboration and contagion: “Virtualisation” of anatomy
during COVID-19. Clin Anat 2020;34:82-89.
30. Wong CS, Tay WC, Hap XF, Chia FL. Love in the time of coronavirus: training and service during COVID-19. Singapore Med J
2020;61:384-6.
31. Corbett KS, Edwards D, Leist SR, et al. SARS-CoV-2 mRNA vaccine development enabled by prototype pathogen preparedness. bioRxiv
2020;145920.
32. Jackson LA, Anderson EJ, Rouphael NG, et al. An mRNA vaccine against SARS-CoV-2 - preliminary report. N Engl J Med
2020;383:1920-31.
33. Tai WB, Zhang XJ, Drelich A, et al. A novel receptor-binding domain (RBD)-based mRNA vaccine against SARS-CoV-2. Cell Res
2020;30:932-935.